TrendFlares logo

Coya Therapeutics, Inc. (COYA)

$6.22 2.64% $0.16 Healthcare

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.

$94.68M

Dr. Howard Berman Ph.D.

6.00

Houston, TX

Dec 29, 2022

-8.41

$-0.74

9.56

10.43

-105.71%

-9.07

0.02

2.60

9.78

10.43

-25.29%

-35.58%

Downtrend

Similar stocks (17)

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.78 -0.52%
Uptrend

Sutro Biopharma, Inc.

STRO

$3.92 -0.76%
Downtrend

TScan Therapeutics, Inc.

TCRX

$5.64 1.81%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.58 5.74%
Downtrend

Fennec Pharmaceuticals Inc.

FENC

$5.29 1.34%
Downtrend

HilleVax, Inc.

HLVX

$1.81 0.00%
Downtrend

Lantern Pharma Inc.

LTRN

$4.07 4.09%
Downtrend

Gain Therapeutics, Inc.

GANX

$1.50 1.01%
Downtrend

Cue Biopharma, Inc.

CUE

$0.56 2.04%
Downtrend

Cognition Therapeutics, Inc.

CGTX

$0.61 1.72%
Downtrend

IN8bio, Inc.

INAB

$0.32 -2.70%
Downtrend

TFF Pharmaceuticals, Inc.

TFFP

$2.31 1.32%
Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 -0.63%
Downtrend

Dermata Therapeutics, Inc.

DRMA

$1.75 -22.22%
Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.02121%

$126.54 2.19%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend